Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

PHASE3CompletedINTERVENTIONAL

Enrollment

1,035

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Staphylococcal Skin Infection

Interventions

DRUG

Telavancin

Telavancin 10 mg/kg/day, IV for up to 14 days.

DRUG

Vancomycin

Vancomycin 1 Gm IV administered every 12 hrs for up to 14 days.

Trial Locations (1)

Louisiana State University Health Sciences Center, Dept of Med/ER Med, New Orleans